Therapeutic strategies that target the metabolic vulnerabilities of tumor cells may have beneficial effects in inhibiting disease progression and enhancing the antitumor immune response by combining lipid uptake with β-oxidation to promote CD8 T cell survival in the setting of lipid-rich tumors. Here, CD8A is linked to neoplasm.